This Giving Tuesday, families and supporters joined us for an exciting update on the breakthroughs accelerating JM research and care.
Executive Director Jim Minow walked through the newest developments in emerging therapies, clinical trials, and next-generation CAR-T approaches.
Dr. Brian Feldman outlined why many clinicians believe we are entering a collaborative breakthrough era for JM treatment.
Live updates from a global JM research meeting in the United Kingdom brought news on JAK inhibitors, clinical trial progress, and innovations that may shape future treatment options.
The event celebrated the momentum in JM science and the impact of our community in driving these advancements.
